熱門資訊> 正文
SI-BONE获得510（k）批准和FDA突破性器械指定
2024-08-20 22:24
- SI-BONE (NASDAQ:SIBN) on Tuesday announced FDA 510(k) clearance of the iFuse TORQ TNT Implant System.
- TNT was awarded Breakthrough Device Designation by the FDA.
- In designating TNT as a Breakthrough Device, the FDA determined that it has the potential to provide more effective treatment of pelvic fragility fractures than the current standard of care, cannulated screws.
- Press release.
More on SI-BONE
- Seeking Alpha’s Quant Rating on SI-BONE
- Historical earnings data for SI-BONE
- Financial information for SI-BONE
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
